Conference Call to Follow Release
DENVER, March 4 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, will report its fourth quarter and year end results on Monday, March 10, 2008, before the market open. The Company will host a conference call at 4:15 p.m. EDT on the same day.
Conference Call Details:
Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and Chief Operating Officer, and Darren Craig, Vice President of Finance, will discuss the fourth quarter and year-end results and will be available to answer questions. The one-hour conference call will be held on Monday, March 10, 2008, at 4:15 p.m. EDT.
Interested parties are welcome to call the telephone numbers listed below five minutes prior to the start of the conference call. Callers within the US should call: 1-866-789-9224. Callers that are outside of the US should call: 1-706-679-9621. Callers should reference "Global Med Technologies Fourth Quarter Earnings Conference Call" to the conference call operator, and the conference call ID number is: 37842682.
An automated replay of the conference call will be available from March 10, 2008 at 5:15 p.m. (EDT) until March 12, 2008 at 11:59 p.m. (EDT). To access the replay, please call 1-800-642-1687 if within the US. Callers that are located outside of the US should call: 1-706-645-9291 and enter Global Med's access code of 37842682.
The replay of the conference call will be available from March 12, 2008 onward at Global Med's website at http://www.globalmedtech.com.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved